This study examines the neural activities of participants undergoing vibro-motor reprocessing therapy (VRT) while experiencing motion sickness. We evaluated the efficacy of vibro-motor reprocessing therapy, a novel therapeutic technique based on eye movement desensitization and reprocessing (EMDR), in reducing motion sickness. Based on visually induced motion sickness in two sets of performed sessions, eight participants were exposed to VRT stimulation in a VRT/non-VRT setting. Simultaneously, brain activity changes were recorded using electroencephalography (EEG) at baseline and during stimulus exposure, and comparisons made across the VRT/non-VRT conditions. A significant reduction in the alpha (8-12 Hz) spectral power was observed in the frontal and occipital locations, consistent across all participants. Furthermore, significant reductions were also found in the frontal and occipital delta (0.5-4 Hz) and theta (4-8 Hz) spectral power frequency bands between non-VRT and VRT conditions (p < 0.05). Our results offer novel insights for a potential nonpharmacological treatment and attenuation of motion sickness. Furthermore, symptoms can be observed, and alleviated, in real-time using the reported techniques. Clinical relevance - Instead of using drugs to treat motion sickness, patients could safely use this VRT technique.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC48229.2022.9871336DOI Listing

Publication Analysis

Top Keywords

motion sickness
24
vibro-motor reprocessing
12
reprocessing therapy
12
spectral power
8
frontal occipital
8
motion
6
sickness
6
therapy managing
4
managing motion
4
sickness reduction
4

Similar Publications

Minimal Detectable Change Scores and Factors Associated With Dynamic Exertion Test (EXiT) Performance After Sport-Related Concussion.

Sports Health

December 2024

University of Pittsburgh Medical Center Sports Medicine Concussion Program, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.

Background: Factors associated with performance outside of a normative range on dynamic exertion test (EXiT) after sport-related concussion (SRC) remain unknown. This study examined the role of demographic and medical history factors on performance using minimal detectable change (MDC) cutoff scores in athletes being cleared to return to sport (RTS) from SRC.

Hypothesis: Older age, being female, and body mass index (BMI) ≥50th percentile would be associated with worse EXiT performance and with increased likelihood of falling outside the normative MDC score range.

View Article and Find Full Text PDF

Background: Whether postoperative nausea and vomiting (PONV) contributes to increased postoperative pain (POP) remains unclear, although POP is reported to cause PONV.

Purpose: This study aimed to determine whether PONV following minor oral surgery (MOS) under general anesthesia increases POP.

Study Design, Setting, Sample: The researchers implemented a retrospective cohort study.

View Article and Find Full Text PDF

Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model.

Diving Hyperb Med

December 2024

Motion Sickness and Human Performance Laboratory, The Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel.

Introduction: Diving utilising closed circuit pure oxygen rebreather systems has become popular in professional settings. One of the hazards the oxygen diver faces is central nervous system oxygen toxicity (CNS-OT), causing potentially fatal convulsions. At the same time, divers frequently travel by boat, often suffering seasickness.

View Article and Find Full Text PDF

Objective: To explore and validate effective eye movement features related to motion sickness (MS) through closed-track experiments and to provide valuable insights for practical applications.

Background: With the development of autonomous vehicles (AVs), MS has attracted more and more attention. Eye movements have great potential to evaluate the severity of MS as an objective quantitative indicator of vestibular function.

View Article and Find Full Text PDF

Introduction: GLP-1 receptor agonists (GLP-1 RAs) have gained traction in the management of obesity. There is limited literature on the implications of GLP-1 RAs in the field of otolaryngology.

Methods: We explore the association between GLP-1 RAs with eustachian tube dysfunction (ETD) and patulous ETD (PETD) by review of cases, literature, and the FDA adverse event database (FAERS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!